Haptoglobin Reagent Market Trends

Growth Drivers

Rising Cases of Kidney Disease to Hike the Growth of the Market - As of 2022, about 80,000 new cases of kidney cancer are estimated to be diagnosed.
Rising Geriatric Population with Severe Renal Diseases - Based on the report provided by World Bank, in 2020, the global geriatric population was 747,238,580.
Growing per Capita Healthcare Expenditure - World Bank released a set of data demonstrating the healthcare expenditure per capita to be USD 1,121.97 in 2019.
Higher Prevalence of Stomach Diseases - National Library of Medicine published a report showing that there were around 17.7 million cases of acute appendicitis in 2019.
Spiking Incidences of Autoimmune Hemolytic Anemia - It observed that warm autoimmune hemolytic anemia (WAHA) affects about 1 to 2 per 100,000 individuals every year.

Challenges

Availability of Alternative Diagnosis Methods
Possibility of Side Effects
Lack of Awareness Toward the Treatment

Haptoglobin Reagent Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	8.2%
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

The haptoglobin reagent industry size is projected to grow at around 8.2% CAGR during the forecast period i.e., between 2024-2036.

Growing per capita healthcare expenditure and higher prevalence of stomach diseases will boost the market growth.

North America industry is predicted to hold largest revenue share by 2036, propelled by rising cases of anemia and kidney diseases in the region.

The major players in the market are Analytik Jena GmbH, Sekisui Diagnostics, LLC, Tecan Trading AG, Beckman Coulter, Inc., Abbott Laboratories, Danaher Corporation, LAB MARK a.s., Kamiya Biomedical Company, and others.

Haptoglobin Reagent Market Trends